Cutler Group’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-8,000
Closed -$14K 6112
2020
Q4
$14K Buy
+8,000
New +$468K ﹤0.01% 2938
2019
Q3
Sell
-10,000
Closed -$11K 4545
2019
Q2
$11K Buy
+10,000
New +$425K ﹤0.01% 2623
2019
Q1
Sell
-23,500
Closed -$17K 4570
2018
Q4
$17K Sell
23,500
-1,100
-4% -$51.3K ﹤0.01% 2219
2018
Q3
$99K Buy
+24,600
New +$1.06M 0.01% 1199
2018
Q2
Sell
-22,500
Closed -$2K 4686
2018
Q1
$2K Buy
22,500
+12,500
+125% +$445K ﹤0.01% 3803
2017
Q4
$29K Buy
10,000
+5,000
+100% +$198K ﹤0.01% 2265
2017
Q3
$7K Buy
5,000
+2,900
+138% +$117K ﹤0.01% 4116
2017
Q2
$8K Sell
2,100
-35,000
-94% -$1.62M ﹤0.01% 4396
2017
Q1
$123K Buy
37,100
+17,700
+91% +$765K 0.01% 1557
2016
Q4
$9K Sell
19,400
-3,400
-15% -$113K ﹤0.01% 4331
2016
Q3
$13K Buy
22,800
+2,100
+10% +$82.3K ﹤0.01% 3904
2016
Q2
$5K Sell
20,700
-30,200
-59% -$1.48M ﹤0.01% 4956
2016
Q1
$151K Buy
50,900
+47,300
+1,314% +$2.77M 0.01% 1220
2015
Q4
$46K Buy
+3,600
New +$204K ﹤0.01% 2558

Other funds holding PCRX